Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements Read more
Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData Read more
Dr Reddy’s presents preclinical data for E7777 (denileukin diftitox) and an immune checkpoint inhibitor at SITC 2020 Read more
Bridge Biotherapeutics, Boehringer Ingelheim cancel agreement to develop BBT-877 for idiopathic pulmonary fibrosis Read more